Beyond the distribution deal, Lunit will also gain access to Salud Digna’s database of deidentified medical images, using them to refine AI algorithms specifically tailored to the Latin American market. Image credit: Lunit.

South Korean AI company Lunit has partnered with Mexican medical network Salud Digna to distribute its AI-based imaging analysis software to more than 230 clinical sites across Mexico and Central America.

The deal covers Lunit’s INSIGHT MMG for mammography diagnostics and analysis and INSIGHT CXR, a software for chest X-ray analysis that recently demonstrated superior performance in tuberculosis (TB) detection in an independent study.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

In the study, published in The Lancet Digital Health, INSIGHT CXR achieved the highest accuracy out of 12 tested AI-based TB detection products. The software displayed 89.9% sensitivity at 67.7% specificity, and an 89.5% sensitivity at 70.2% specificity, meeting the World Health Organization’s (WHO) target product profile.

Lunit said the partnership means Salud Digna’s network clinicians will gain the ability to conduct faster, more accurate imaging analysis while enabling access to Salud Digna’s extensive database of deidentified medical images, which it will utilise to refine AI algorithms specifically tailored to the Latin American market.

In addition, Lunit stated that, unlike typical partnerships of this nature, it will also work with Salud Digna on research projects aimed at the further development of medical imaging AI to improve healthcare delivery across the region.

Salud Digna CEO Juan Carlos Ordoñez said: “By integrating Lunit’s advanced AI into our healthcare network, we aim to improve the accuracy and efficiency of our imaging services.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Together, we are committed to leveraging our extensive data resources to drive innovation in medical imaging and ultimately improve patient care across the region.”

In 2022, Lunit obtained a CE mark under the EU’s revised Medical Device Regulation (MDR) and a UK Conformity Assessed (UKCA) marking for Lunit INSIGHT, its suite of AI solutions for radiology, becoming the first software as a medical device (SaMD) company in the Asia Pacific region to do so.

GlobalData’s 2023 AI in Healthcare report forecasts that AI platforms across healthcare will reach a global valuation of $18.8bn by 2027.